Medicare Enrolled
Dr. Ilicia Shugarman, M.D.
Internal Medicine · Neptune Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shugarman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shugarman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shugarman
Dr. Ilicia Shugarman is an internal medicine specialist in Neptune Beach, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Shugarman performed 92,288 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shugarman received a total of $4,164 from 57 pharmaceutical and/or device companies across 284 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shugarman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years of NPI registration
▲ Top 0% volume in FL
$4,164 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 122974 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗92,288
Medicare services
Top 0% in FL for internal medicine
Not available
Unique patients (not deduplicated)
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 25,600 | $43 | $108 |
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
25,500 | $1 | $4 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
8,400 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 7,440 | $18 | $40 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,150 | $0 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
3,600 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,500 | $6 | $27 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,055 | $8 | $41 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,974 | $8 | $18 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,958 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 930 | $0 | $41 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
861 | $62 | $104 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
704 | $96 | $162 |
| Anti-nausea injection (Aloxi/palonosetron) | 700 | $1 | $75 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
413 | $97 | $355 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
403 | $22 | $90 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
352 | $10 | $42 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
144 | $47 | $160 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
143 | $7 | $282 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
105 | $1 | $4 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
100 | $62 | $115 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
96 | $1 | $7 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
91 | $70 | $70 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
90 | $49 | $175 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
88 | $22 | $80 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
87 | $12 | $55 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
84 | $10 | $40 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
74 | $46 | $500 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
71 | $15 | $45 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
61 | $24 | $130 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
57 | $155 | $535 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
50 | $93 | $160 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
44 | $2 | $97 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
43 | $101 | $225 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 41 | $401 | $1,000 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
40 | $1,090 | $2,400 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
34 | $1 | $21 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
32 | $66 | $153 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
28 | $39 | $310 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $74 | $181 |
| New patient office visit, complex (60-74 min) | 25 | $168 | $340 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
24 | $24 | $84 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
23 | $134 | $235 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
19 | $5 | $29 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $137 | $330 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $131 | $265 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
29.0% high complexity
64.3% medium
6.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,164
Total received (2018-2024)
Avg $595/year across 7 years
Top 16% in FL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
284
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$957
2023
$535
2022
$248
2021
$280
2020
$408
2019
$930
2018
$806
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$204
Janssen Biotech, Inc.
$158
PFIZER INC.
$154
AstraZeneca Pharmaceuticals LP
$47
Daiichi Sankyo Inc.
$42
BeiGene USA, Inc.
$38
Celgene Corporation
$35
Exelixis Inc.
$34
Genentech USA, Inc.
$34
ABBVIE INC.
$31
E.R. Squibb & Sons, L.L.C.
$29
Alnylam Pharmaceuticals Inc.
$26
Tempus AI, Inc
$22
GlaxoSmithKline, LLC.
$22
ARRAY BIOPHARMA INC
$20
ADC Therapeutics America, Inc.
$20
Lilly USA, LLC
$14
SOBI, INC
$14
GENZYME CORPORATION
$13
Top 3 companies account for 53.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$698
Janssen Biotech, Inc.
$541
PFIZER INC.
$519
Genentech USA, Inc.
$194
E.R. Squibb & Sons, L.L.C.
$185
Merck Sharp & Dohme Corporation
$180
Janssen Pharmaceuticals, Inc
$176
Daiichi Sankyo Inc.
$117
BeiGene USA, Inc.
$105
Foundation Medicine, Inc.
$102
GENZYME CORPORATION
$98
AstraZeneca Pharmaceuticals LP
$95
Amgen Inc.
$77
Alnylam Pharmaceuticals Inc.
$72
Incyte Corporation
$61
Celgene Corporation
$54
Lexicon Pharmaceuticals, Inc.
$51
Exelixis Inc.
$50
Karyopharm Therapeutics Inc.
$50
Acrotech Biopharma Inc.
$42
Taiho Oncology, Inc.
$37
GlaxoSmithKline, LLC.
$34
MEDIVATION FIELD SOLUTIONS LLC
$32
Takeda Pharmaceuticals U.S.A., Inc.
$32
ABBVIE INC.
$31
Gilead Sciences, Inc.
$30
Shield Therapeutics Inc
$27
Alexion Pharmaceuticals, Inc.
$27
Lilly USA, LLC
$26
MorphoSys, US Inc.
$25
Astellas Pharma US Inc
$24
Tempus AI, Inc
$22
Mirati Therapeutics, Inc.
$22
Octapharma USA, Inc.
$20
ARRAY BIOPHARMA INC
$20
ADC Therapeutics America, Inc.
$20
EUSA Pharma (US) LLC
$17
INSYS Therapeutics Inc
$16
Kyowa Kirin, Inc.
$16
Rigel Pharmaceuticals, Inc.
$16
Global Blood Therapeutics, Inc.
$15
SOBI, INC
$14
AMAG Pharmaceuticals, Inc.
$14
TG Therapeutics, Inc.
$13
Stemline Therapeutics Inc.
$13
EMD Serono, Inc.
$13
Secura Bio, Inc.
$12
Boehringer Ingelheim Pharmaceuticals, Inc.
$12
Eisai Inc.
$12
Aurobindo Pharma USA, Inc.
$12
Bayer HealthCare Pharmaceuticals Inc.
$11
Regeneron Healthcare Solutions, Inc.
$11
Pharmacyclics LLC, An AbbVie Company
$11
Puma Biotechnology, Inc.
$11
TESARO, Inc.
$11
Clovis Oncology, Inc.
$10
ADMA BioManufacturing LLC
$9
Top 3 companies account for 42.2% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · AFINITOR · BELEODAQ · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · CEREZYME · CYRAMZA · Cabometyx · DARZALEX · ELIQUIS · ELREXFIO · EMPLICITI · ERLEADA · EVENITY · Enhertu · Erleada · FERAHEME · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · Nubeqa · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · Polivy · REBLOZYL · RYBREVANT · RYDAPT · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIRIS · SUTENT · SYNDROS · Sylvant · TAGRISSO · TASIGNA · TIVDAK · Tavalisse · Tecentriq · Trodelvy · UKONIQ · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VPRIV · Vanflyta · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · ZEJULA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
930
County median income
$68,447
Nearest hospital to ZIP centroid (approximate)
BAPTIST MEDICAL CENTER BEACHES
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shugarman is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shugarman experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Shugarman performed 25,600 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shugarman receive payments from pharmaceutical companies?
Yes. Dr. Shugarman received a total of $4,164 from 57 companies across 284 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shugarman's costs compare to other internal medicine physicians in Neptune Beach?
Dr. Shugarman's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shugarman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Neptune Beach
Browse internal medicine physicians in Neptune Beach ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in FL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in FL
Which FL internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology